These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28440812)

  • 21. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Speaking fluently with baclofen?
    Beraha E; Bodewits P; van den Brink W; Wiers R
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28495786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
    Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
    J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety.
    Morley KC; Baillie A; Leung S; Addolorato G; Leggio L; Haber PS
    Alcohol Alcohol; 2014 Nov; 49(6):654-60. PubMed ID: 25246489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder.
    Haass-Koffler CL; Perciballi R; Magill M; Loche A; Cacciaglia R; Leggio L; Swift RM
    Psychopharmacology (Berl); 2022 Jan; 239(1):35-46. PubMed ID: 34731268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.
    Simioni N; Labreuche J; Behal H; Cottencin O; Rolland B
    J Clin Psychopharmacol; 2017 Dec; 37(6):722-728. PubMed ID: 28984747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study.
    Khemiri L; Steensland P; Guterstam J; Beck O; Carlsson A; Franck J; Jayaram-Lindström N
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2240-51. PubMed ID: 26482910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
    Ray LA; Chin PF; Heydari A; Miotto K
    Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
    Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence.
    Logge W; Baillie A; Haber P; Towers E; Riordan BC; Morley K
    Addict Behav; 2023 Jan; 136():107462. PubMed ID: 36084413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
    Morley KC; Leung S; Baillie A; Haber PS
    Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers.
    Leggio L; Zywiak WH; Edwards SM; Tidey JW; Swift RM; Kenna GA
    Psychopharmacology (Berl); 2015 Jan; 232(1):233-43. PubMed ID: 24973894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.
    Leggio L; Zywiak WH; Fricchione SR; Edwards SM; de la Monte SM; Swift RM; Kenna GA
    Biol Psychiatry; 2014 Nov; 76(9):734-41. PubMed ID: 24775991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.
    Schwandt ML; Cortes CR; Kwako LE; George DT; Momenan R; Sinha R; Grigoriadis DE; Pich EM; Leggio L; Heilig M
    Neuropsychopharmacology; 2016 Nov; 41(12):2818-2829. PubMed ID: 27109623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of tryptophan depletion on alcohol self-administration in non-treatment-seeking alcoholic individuals.
    Petrakis IL; Buonopane A; O'Malley S; Cermik O; Trevisan L; Boutros NN; Limoncelli D; Krystal JH
    Alcohol Clin Exp Res; 2002 Jul; 26(7):969-75. PubMed ID: 12170105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baclofen for the treatment of alcohol dependence.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):11-4. PubMed ID: 22998536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
    Addolorato G; Leggio L
    Curr Pharm Des; 2010; 16(19):2113-7. PubMed ID: 20482507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baclofen for alcohol use disorder-a systematic meta-analysis.
    Bschor T; Henssler J; Müller M; Baethge C
    Acta Psychiatr Scand; 2018 Sep; 138(3):232-242. PubMed ID: 29888478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total and acylated ghrelin plasma levels as potential long-term response markers in alcohol-dependent patients receiving high-dose of the GABA-B receptor agonist baclofen.
    Geisel O; Hellweg R; Wernecke KD; Wiedemann K; Müller CA
    Psychiatry Res; 2019 Feb; 272():431-437. PubMed ID: 30611960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.